François Ghiringhelli

Inserm

Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index108
i10-index361
Publications976
Citations59,534

Grants

No NSF/NIH grants on record.

Recent Public Signals

  1. New paper: Supplementary Figure S2 from The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer2026-07-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-20

Data may not be current

Find elsewhere

ORCID: 0000-0002-5465-8305

Professor Insights

Career Trajectory